Conference abstract · 2020
Conference abstractPublished 27 Jul 2020
Automation in Pharmacovigilance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In today’s world of empowered patients and increased attention to drug safety, the role of Pharmacovigilance has never been more crucial. Healthcare organizations need to instill robust practices to detect, assess, report on and prevent adverse effects, both to ensure regulatory compliance and reduce risk for patients. Pharmacovigilance processes, however, are traditionally highly manual and resource-intensive. As such, adverse events are reported across the globe in multiple languages and formats and in structured, unstructured and handwritten documents from affiliates, partners and distributors. Typically, large Pharma companies receive anywhere from 300,000 to 500,000 adverse events a year. These documents are processed manually by large teams that identify and extract relevant information and enter it into the safety system. This is followed by quality and medical review before the data is reported to regulatory bodies. Automation of pharmaceutical safety case processing represents a significant opportunity to affect the strongest cost driver for a company’s overall Pharmacovigilance budget.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 17 Jul 2017
Efficiency gain in business models for global pharmacovigilance: - Automation and burying the silos
Conference abstract
Efficiency gain in business models for global pharmacovigilance: Automation and burying the silos
Article · 19 Jun 2026
Advancing Patient Safety Through Modern Pharmacovigilance Practices
Article · 12 Mar 2026
Integrated Safety Monitoring Approaches in Clinical Trials Through Pharmacovigilance Systems
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sunil Nighot”
